Glanzmann's thrombasthenia: the spectrum of clinical disease.

In this review the data on 177 patients are analyzed: previously published data on 113 patients are supplemented with the description of 64 patients who have been studied in Paris over the past 33 years

[1]  S. B. Mckenzie Textbook of Hematology , 1988 .

[2]  J. Bernard History of congenital hemorrhagic thrombocytopathic dystrophy. , 1983, Blood cells.

[3]  J. Caen,et al.  An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia , 1974, British journal of haematology.

[4]  J. Moake,et al.  Bernard‐Soulier Disease: a Study of Four Patients and their Parents , 1981, British journal of haematology.

[5]  U. Seligsohn,et al.  A Glanzmann’s Thrombasthenia Cluster Among Iraqi Jews in Israel , 1984, Thrombosis and Haemostasis.

[6]  A. Awidi,et al.  Increased incidence of Glanzmann's thrombasthenia in Jordan as compared with Scandinavia. , 2009, Scandinavian journal of haematology.

[7]  R. Casper,et al.  Dysfunctional Uterine Bleeding , 2018, Caring for the Hospitalized Child.

[8]  M. Price,et al.  The expression of glycoproteins on single blood platelets from healthy individuals and from patients with congenital bleeding disorders. , 1984, Biochemical and biophysical research communications.

[9]  H. Weiss,et al.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. , 1989, The Journal of clinical investigation.

[10]  C. Legrand,et al.  Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. , 1989, Blood.

[11]  N. Aoki,et al.  Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight. , 1988, Blood.

[12]  W. Vainchenker,et al.  Monoclonal antibodies specific for human platelet membrane glycoproteins bind to monocytes by focal absorption of platelet membrane fragments: an ultrastructural immunogold study. , 1987, Leukemia.

[13]  A. Nurden Glycoprotein Defects Responsible for Abnormal Platelet Function in Inherited Platelet Disorders , 1985 .

[14]  E. Rabellino,et al.  Platelet glycoproteins IIb and IIIa associated with blood monocytes are derived from platelets , 1986 .

[15]  J. Pritchard,et al.  BLOOD VOLUME CHANGES IN PREGNANCY AND THE PUERPERIUM. III. WHOLE BODY AND LARGE VESSEL HEMATOCRITS IN PREGNANT AND NONPREGNANT WOMEN. , 1962, American journal of obstetrics and gynecology.

[16]  K. Simpkins A Textbook of Radiology and Imaging , 1981 .

[17]  B. Coller,et al.  Inhibition of human platelet function in vivo with a monoclonal antibody. With observations on the newly dead as experimental subjects. , 1988, Annals of internal medicine.

[18]  H. Gold,et al.  Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. , 1988, The Journal of clinical investigation.

[19]  C. Legrand,et al.  A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. , 1987, The Journal of clinical investigation.

[20]  J. Sixma,et al.  The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendothelium , 1986, British journal of haematology.

[21]  J. Caen 5 Glanzmann's thrombasthenia , 1989 .

[22]  O. Bjerrum,et al.  Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. , 1980, The Journal of clinical investigation.

[23]  J. Soulier,et al.  Thrombasthénie de Glanzmann antigène PlA1 et anticorps anti-Glanzmann , 1978 .

[24]  I. Cameron 6 Dysfunctional uterine bleeding , 1989 .

[25]  B. Coller,et al.  Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. , 1986, The Journal of laboratory and clinical medicine.

[26]  E. Reardon,et al.  Angiography and embolization of the internal maxillary artery for posterior epistaxis. , 1979, Archives of otolaryngology.

[27]  J. F. Wallace,et al.  CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. , 1965, The New England journal of medicine.

[28]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[29]  N. Kieffer,et al.  Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia. , 1985, Blood.

[30]  S. Pereira,et al.  Glanzmann’s Thrombasthenia , 1981, Thrombosis and Haemostasis.

[31]  D. Ogston Current status of antifibrinolytic drugs. , 1989, Blood reviews.

[32]  C. Cowell,et al.  Acute adolescent menorrhagia. , 1981, American journal of obstetrics and gynecology.

[33]  B. Steinberg,et al.  Establishment and transformation diminish the ability of fibroblasts to contract a native collagen gel , 1980, The Journal of cell biology.

[34]  E. Rossi,et al.  Disorders of platelet function. , 1972, The Medical clinics of North America.

[35]  G. Stickler,et al.  Petechiae in the newborn infant. , 1961, American journal of diseases of children.

[36]  M. Baggiolini,et al.  ABSENCE OF PLATELET MEMBRANE GLYCOPROTEINS , 1985 .

[37]  Mannucci Pm Desmopressin (DDAVP) for treatment of disorders of hemostasis. , 1986 .

[38]  M. Hilgartner,et al.  Platelet function in a patient with thrombasthenia. , 1966, Blood.

[39]  Paul J. Harrison,et al.  Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. , 1989, The Journal of clinical investigation.

[40]  A. Nurden,et al.  Relationship between Fibrinogen Binding and the Platelet Glycoprotein Deficiencies in Glanzmann's Thrombasthenia Type I and Type II , 1981, British journal of haematology.

[41]  M. Shuman,et al.  Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. , 1989, The Journal of clinical investigation.

[42]  M. Ginsberg,et al.  Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. , 1989, Progress in hemostasis and thrombosis.

[43]  P. Mannucci,et al.  Binding of fibrinogen to human monocytes. , 1986, The Journal of clinical investigation.

[44]  C. Legrand,et al.  Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay. , 1989, Thrombosis research.

[45]  A. Vries,et al.  Thrombocytopathic Purpura with Normal Prothrombin Consumption , 1953 .

[46]  M. Mancini,et al.  A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. , 1986, The Journal of clinical investigation.

[47]  I. Cohen,et al.  THROMBASTHENIA: A STUDY OF TWO SIBLINGS , 1968, Acta paediatrica Scandinavica.

[48]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[49]  N. Ardaillou,et al.  A molecular defect in thrombasthenic platelets. , 1975, The Journal of clinical investigation.

[50]  C. Legrand,et al.  Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function , 1978 .

[51]  L. Parise,et al.  LA Fitzgerald The platelet membrane glycoprotein IIb-IIIa complex , 1988 .

[52]  H. Gold,et al.  Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. , 1988, Circulation.

[53]  P. N. Walsh,et al.  Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled Trial , 1971, British journal of haematology.

[54]  N. Nara,et al.  Autoantibody against platelet glycoprotein IIb/IIIa in a patient with non-Hodgkin's lymphoma. , 1989, Thrombosis research.

[55]  D. Blockmans,et al.  10 Acquired disorders of platelet function , 1989 .

[56]  B. Coller,et al.  Immunoblot analysis of platelet glyeoprotein IIb in patients with Glanzmann thrombasthenia in Israel , 1989, British journal of haematology.

[57]  W. Vainchenker,et al.  Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. , 1989, Blood.

[58]  R. Bick Disorders of Hemostasis and Thrombosis , 1985 .

[59]  J. Cazenave,et al.  Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia. , 1981, The Journal of clinical investigation.

[60]  J. V. van Mourik,et al.  NORMAL SYNTHESIS AND EXPRESSION OF ENDOTHELIAL GP IIb/IIIa IN GLANZMANN'S THROMBASTENIA , 1987, Thrombosis and Haemostasis.

[61]  M. Boiron,et al.  Complete correction of Glanzmann's thrombasthenia by allogeneic bone‐marrow transplantation , 1985, British journal of haematology.

[62]  U. Seligsohn,et al.  Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis , 1987 .

[63]  G. Gogstad,et al.  Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I. , 1983, The Biochemical journal.

[64]  P. Majerus,et al.  Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. , 1980, The Journal of clinical investigation.

[65]  A. Kaufmann,et al.  Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. , 1986, The Journal of clinical investigation.

[66]  C. Legrand,et al.  Studies on Platelets of Patients with Inherited Platelet Disorders Suggest that Collagen-Induced Fibrinogen Binding to Membrane Receptors Requires Secreted ADP but Not Released α-Granule Proteins , 1985, Thrombosis and Haemostasis.

[67]  J. George,et al.  Molecular defects in interactions of platelets with the vessel wall. , 1984, The New England journal of medicine.

[68]  E. Bowie,et al.  FAMILIAL GLANZMANN'S THROMBASTHENIA. , 1964, Mayo Clinic proceedings.

[69]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[70]  D. Cheresh,et al.  Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. , 1989, The Journal of biological chemistry.

[71]  C. Kitchens Occult hemophilia. , 1980, The Johns Hopkins medical journal.

[72]  A. Nurden,et al.  The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. , 1979, Seminars in hematology.

[73]  J. Levin,et al.  A Critical Reappraisal of the Bleeding Time* , 1990, Seminars in thrombosis and hemostasis.

[74]  G. Remuzzi,et al.  Skin fibroblasts from a patient with Glanzmann's thrombasthenia do not induce fibrin clot retraction. , 1977, Thrombosis research.

[75]  S. Hanson,et al.  Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. , 1988, The Journal of clinical investigation.

[76]  P. Bierling,et al.  Early Immunization against Platelet Glycoprotein Ilia in a Newborn Glanzmann Type I Patient , 1988, Vox sanguinis.

[77]  P. Walsh Platelet Coagulant Activities in Thrombasthenia , 1972, British journal of haematology.

[78]  H. Weiss,et al.  Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. , 1986, Blood.

[79]  A. Nurden Abnormalities of platelet glycoproteins in inherited disorders of platelet function , 1987 .

[80]  落合 和徳 NOVAK'S Textbook of Gynecology 11th edition, Jones III, H.W. and Wentz A.C., Williams & Wilkins \15,120 (医学書院 洋書部 調べ) , 1989 .

[81]  M. Poncz,et al.  A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia. , 1991, The Journal of clinical investigation.

[82]  R. Sessions Nasal Hemorrhage. , 1973, Otolaryngologic clinics of North America.

[83]  B. Bull,et al.  The immunogenicity of platelet membrane glycoproteins. , 1987, Transfusion medicine reviews.

[84]  C. Alfrey,et al.  Glanzmann's Thrombasthenia; Assessment of the Response to Platelet Transfusions , 2003, Transfusion.

[85]  P. Mannucci Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. , 1988, Blood.